USP22 and hepatocellular carcinoma: Studies have reported a novel oncogenic mechanism of lncRNA HULC, driving abnormal tumor proliferation through the “HULC-USP22-PTGS2” molecular regulatory circuit in hepatocellular carcinoma (HCC) [19].